Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica.
Navigating the Decision Space: Shared Medical Decision Making as Distributed Cognition.
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis.
Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis.
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.
Anterograde-propagation of axonal degeneration in the visual system of wlds mice characterized by diffusion tensor imaging.
Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
An Approach to Enhance Alignment and Myelination of Dorsal Root Ganglion Neurons.
Statistical estimation of white matter microstructure from conventional MRI.
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.
Arzerra receives approval in Japan
Performance of F2 B6x129 hybrid mice in the Morris water maze, latent inhibition and prepulse inhibition paradigms: Comparison with C57Bl/6J and 129sv inbred mice.
Metabolic determinants of the immune modulatory function of neural stem cells.
Evidence in sexual assault case ruled out.
MEG evaluation of pico-Tesla external TMS on multiple sclerosis patients.
Potential Benefit of the Charge-Stabilized Nanostructure Saline RNS60 for Myelin Maintenance and Repair.
Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations.
Reduced fecal GABA levels in multiple sclerosis patients.
NG2-glia, More Than Progenitor Cells.
Candida utilis and Cyberlindnera (Pichia) jadinii: yeast relatives with expanding applications.
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency.
Predictors of static balance in ambulatory persons with multiple sclerosis.
Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system.
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
Pages
« first
‹ previous
…
712
713
714
715
716
717
718
719
720
…
next ›
last »